Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological study of lapatinib effect on apoptosis in HER2-positive DCIS breast cancer
2008-004492-21Phase 2Completed
- Sponsor
- Fundación de Investigación HM Hospitales
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in ductal carcinoma in situ (DCIS), sponsored by Fundación de Investigación HM Hospitales. Primary endpoint: Change in apoptosis index by TUNEL. Started Jul 2008; status: completed.
02
Drugs
lapatinib
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on 2008-004492-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004492-21.